Gliklazid MB Pharmstandard, 60 mg 30 pcs
€6.12 €5.44
Orderal hypoglycemic agent, sulfonylurea derivative of the II generation. Stimulates insulin secretion by pancreatic β-cells. Increases the sensitivity of peripheral tissues to insulin. Apparently stimulates activity of intracellular enzymes (in particular, muscle glycogen synthetase). Reduces the time interval from the moment of food intake to the beginning of insulin secretion. Restores the early peak of insulin secretion, reduces the postprandial peak of hyperglycemia.
Glyclazide reduces platelet adhesion and aggregation, slows the development of parietal thrombus, increases vascular fibrinolytic activity. It normalizes vascular permeability.
It has anti-atherogenic properties: lowers the blood concentration of total cholesterol (CH) and LDL, increases the concentration of HDL and reduces the amount of free radicals. Prevents the development of microthrombosis and atherosclerosis. Improves microcirculation. Reduces the sensitivity of blood vessels to adrenaline.
In diabetic nephropathy with long-term use of gliclazide there is a significant reduction of proteinuria.
Indications
Type 2 diabetes mellitus with insufficient effectiveness of diet therapy, physical activity and weight reduction.
Prevention of complications of type 2 diabetes: reducing the risk of microvascular (nephropathy, retinopathy) and macrovascular complications (myocardial infarction, stroke).
Active ingredient
How to take, the dosage
Interaction
Special Instructions
Contraindications
– hypersensitivity to gliclazide or any of the excipients of the drug, to other sulfonylurea derivatives, to sulfonamides;
– diabetes mellitus type 1;
– diabetic ketoacidosis, diabetic precoma, diabetic coma; . – severe renal and/or hepatic failure;
– pregnancy and lactation period;
– age under 18 years;
– taking miconazole;
– congenital lactose intolerance, lactase deficiency or glucose-galactose malabsorption.
It is not recommended to use the drug simultaneously in combination with phenylbutazone or danazol.
Side effects
Overdose
Similarities
Weight | 0.020 kg |
---|---|
Shelf life | 3 years. |
Conditions of storage | List B. In a dry, light-protected place at a temperature not exceeding 25 °С. |
Manufacturer | Pharmstandard-Leksredstva, Russia |
Medication form | sustained release tablets |
Brand | Pharmstandard-Leksredstva |
Other forms…
Related products
Buy Gliklazid MB Pharmstandard, 60 mg 30 pcs with delivery to USA, UK, Europe and over 120 other countries.